HC Wainwright Reiterates Buy Rating for IceCure Medical (NASDAQ:ICCM)

IceCure Medical (NASDAQ:ICCM)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a report issued on Wednesday,Benzinga reports. They presently have a $2.50 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 200.41% from the company’s current price.

Separately, Alliance Global Partners raised shares of IceCure Medical to a “strong-buy” rating in a report on Friday, November 1st.

IceCure Medical Stock Performance

IceCure Medical stock opened at $0.83 on Wednesday. IceCure Medical has a 1-year low of $0.48 and a 1-year high of $1.57. The company has a current ratio of 2.97, a quick ratio of 2.54 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $37.96 million, a PE ratio of -2.77 and a beta of 0.48. The firm’s 50 day simple moving average is $0.65 and its 200 day simple moving average is $0.73.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in IceCure Medical stock. Renaissance Technologies LLC bought a new stake in IceCure Medical Ltd (NASDAQ:ICCM) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 66,400 shares of the company’s stock, valued at approximately $49,000. Renaissance Technologies LLC owned about 0.15% of IceCure Medical as of its most recent SEC filing. Institutional investors and hedge funds own 0.62% of the company’s stock.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.